XML 34 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets (in thousands):
March 31, 2024December 31, 2023
Cash and cash equivalents$53,780 $62,888 
Restricted cash, non-current64 64 
Total cash, cash equivalents and restricted cash $53,844 $62,952 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets (in thousands):
March 31, 2024December 31, 2023
Cash and cash equivalents$53,780 $62,888 
Restricted cash, non-current64 64 
Total cash, cash equivalents and restricted cash $53,844 $62,952 
Schedule of Inventory
Details of inventory are presented as follows (in thousands):
March 31, 2024December 31, 2023
Raw materials$3,606 $4,640 
Work in process1,660 1,366 
Finished goods670 421 
Total $5,936 $6,427 
Schedule of Property, Plant and Equipment
Details of property and equipment are presented as follows (in thousands):
March 31, 2024December 31, 2023
Computers and Software$471 $464 
Construction in process5,312 4,389 
Furniture and fixtures65 65 
Lab equipment25 25 
Leasehold improvements133 129 
Total$6,006 $5,072 
Accumulated depreciation(320)(270)
Property and equipment, net$5,686 $4,802 
Schedule Of Gross-To-Net Sales Adjustments
The following table sets forth the changes in the accrued revenue allowances (in thousands):
As of March 31,
20242023
Balance at beginning of period$1,065$1,434
Provision for current period sales1,0841,035
Payments(1,292)(553)
Balance at end of period$857$1,916
Schedule of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss Per Share
The following table sets forth the outstanding potentially dilutive securities that have been excluded in the calculation of diluted net loss per share because their inclusion would be anti-dilutive:
Three Months Ended March 31,
20242023
Options to purchase common stock5,372,887 3,846,365 
Restricted Stock Units to purchase common stock341,258 — 
Warrants to purchase common stock29,167 29,167